JP2023514437A5 - - Google Patents

Info

Publication number
JP2023514437A5
JP2023514437A5 JP2022550813A JP2022550813A JP2023514437A5 JP 2023514437 A5 JP2023514437 A5 JP 2023514437A5 JP 2022550813 A JP2022550813 A JP 2022550813A JP 2022550813 A JP2022550813 A JP 2022550813A JP 2023514437 A5 JP2023514437 A5 JP 2023514437A5
Authority
JP
Japan
Prior art keywords
sequence number
sequence
optionally
lcdr2
hcdr1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022550813A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023514437A (ja
JP7858536B2 (ja
Filing date
Publication date
Priority claimed from GBGB2002581.3A external-priority patent/GB202002581D0/en
Application filed filed Critical
Publication of JP2023514437A publication Critical patent/JP2023514437A/ja
Publication of JP2023514437A5 publication Critical patent/JP2023514437A5/ja
Priority to JP2026007486A priority Critical patent/JP2026086466A/ja
Application granted granted Critical
Publication of JP7858536B2 publication Critical patent/JP7858536B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022550813A 2020-02-24 2021-02-24 Ex vivoガンマデルタt細胞集団 Active JP7858536B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026007486A JP2026086466A (ja) 2020-02-24 2026-01-20 Ex vivoガンマデルタt細胞集団

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB2002581.3A GB202002581D0 (en) 2020-02-24 2020-02-24 Novel antibodies
GB2002581.3 2020-02-24
PCT/GB2021/050460 WO2021171003A1 (en) 2020-02-24 2021-02-24 Ex vivo gamma delta t cell populations

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026007486A Division JP2026086466A (ja) 2020-02-24 2026-01-20 Ex vivoガンマデルタt細胞集団

Publications (3)

Publication Number Publication Date
JP2023514437A JP2023514437A (ja) 2023-04-05
JP2023514437A5 true JP2023514437A5 (cg-RX-API-DMAC7.html) 2024-01-30
JP7858536B2 JP7858536B2 (ja) 2026-05-14

Family

ID=70108379

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2022550778A Pending JP2023516925A (ja) 2020-02-24 2021-02-24 新規の抗体
JP2022550813A Active JP7858536B2 (ja) 2020-02-24 2021-02-24 Ex vivoガンマデルタt細胞集団
JP2026007486A Pending JP2026086466A (ja) 2020-02-24 2026-01-20 Ex vivoガンマデルタt細胞集団

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2022550778A Pending JP2023516925A (ja) 2020-02-24 2021-02-24 新規の抗体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026007486A Pending JP2026086466A (ja) 2020-02-24 2026-01-20 Ex vivoガンマデルタt細胞集団

Country Status (17)

Country Link
US (2) US20230159638A1 (cg-RX-API-DMAC7.html)
EP (3) EP4110813A1 (cg-RX-API-DMAC7.html)
JP (3) JP2023516925A (cg-RX-API-DMAC7.html)
KR (2) KR20220164473A (cg-RX-API-DMAC7.html)
CN (2) CN115697401A (cg-RX-API-DMAC7.html)
AU (2) AU2021228266A1 (cg-RX-API-DMAC7.html)
BR (2) BR112022016894A2 (cg-RX-API-DMAC7.html)
CA (2) CA3168973A1 (cg-RX-API-DMAC7.html)
CL (1) CL2022002296A1 (cg-RX-API-DMAC7.html)
CO (2) CO2022013542A2 (cg-RX-API-DMAC7.html)
EC (1) ECSP22074030A (cg-RX-API-DMAC7.html)
GB (1) GB202002581D0 (cg-RX-API-DMAC7.html)
IL (2) IL295696A (cg-RX-API-DMAC7.html)
MX (2) MX2022010383A (cg-RX-API-DMAC7.html)
PE (1) PE20230438A1 (cg-RX-API-DMAC7.html)
WO (2) WO2021171003A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202209699B (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202006989D0 (en) * 2020-05-12 2020-06-24 Gammadelta Therapeutics Ltd Methods for isolating gamma delta t cells
KR20230160253A (ko) 2021-02-17 2023-11-23 감마델타 테라퓨틱스 엘티디 항-tcr 델타 가변 1 항체
MX2023009544A (es) 2021-02-17 2023-11-28 Gammadelta Therapeutics Ltd Anticuerpos anti-variable delta 1 de tcr multiespecíficos.
CN119080924B (zh) * 2024-07-04 2025-02-25 上海交通大学医学院附属第九人民医院 一种单克隆免疫球蛋白及其用途

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003210060B2 (en) 2002-03-22 2010-02-25 Aprogen, Inc. Humanized antibody and process for preparing same
CN100591761C (zh) 2004-08-19 2010-02-24 加的夫大学学院咨询有限公司 呈递抗原的人γδT细胞的制备和在免疫治疗中的用途
CN102453701B (zh) * 2010-10-26 2014-08-13 中国医学科学院基础医学研究所 基因修饰CDR3δ移植型γδT淋巴细胞及其抑癌用途
CN105859889B (zh) 2010-11-17 2020-01-07 中外制药株式会社 具有代替凝血因子viii的功能的功能的多特异性抗原结合分子
US8790651B2 (en) 2011-07-21 2014-07-29 Zoetis Llc Interleukin-31 monoclonal antibody
GB201506423D0 (en) 2015-04-15 2015-05-27 Tc Biopharm Ltd Gamma delta T cells and uses thereof
RU2756247C2 (ru) * 2014-11-17 2021-09-28 Эдисет Био, Инк. Генетически модифицированные гамма дельта т-клетки
GB201507368D0 (en) * 2015-04-30 2015-06-17 Ucl Business Plc Cell
JP6799895B2 (ja) * 2015-06-09 2020-12-16 リンファクト−リンフォサイト アクティベイション テクノロジーズ エス.エー. TCRγδ+T細胞の生産方法
US10946095B2 (en) 2015-09-02 2021-03-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Antibodies specific to human T-cell immunoglobulin and ITIM domain (TIGIT)
US10456211B2 (en) 2015-11-04 2019-10-29 Medicrea International Methods and apparatus for spinal reconstructive surgery and measuring spinal length and intervertebral spacing, tension and rotation
PE20190115A1 (es) 2016-04-15 2019-01-16 Immunext Inc Anticuerpos vista antihumanos y su uso
CN118421557A (zh) 2016-05-12 2024-08-02 阿迪塞特治疗公司 选择性扩增γδT细胞群的方法及其组合物
GB201612520D0 (en) 2016-07-19 2016-08-31 F-Star Beta Ltd Binding molecules
WO2019005637A2 (en) 2017-06-25 2019-01-03 Systimmune, Inc. MULTIPECIFIC ANTIBODIES AND METHODS OF PRODUCTION AND USE THEREOF
WO2019147735A1 (en) 2018-01-23 2019-08-01 New York University Antibodies specific to delta 1 chain of t cell receptor
JP7457007B2 (ja) 2018-09-19 2024-03-27 ラヴァ・セラピューティクス・エヌ・ヴイ 二重作用CD1d免疫グロブリン
GB201818243D0 (en) 2018-11-08 2018-12-26 Gammadelta Therapeutics Ltd Methods for isolating and expanding cells
CA3127103A1 (en) 2019-01-23 2020-07-30 New York University Antibodies specific to delta 1 chain of t cell receptor
WO2020159368A1 (en) 2019-02-01 2020-08-06 Lava Therapeutics B.V. Novel cd40-binding antibodies
CA3136251A1 (en) 2019-04-08 2020-10-15 Memorial Sloan Kettering Cancer Center Cd19 antibodies and methods of using the same
CA3148588A1 (en) 2019-08-16 2021-02-25 GammaDelta Therapeutics Limited Ex vivo gamma delta t cell populations
JP2022545196A (ja) * 2019-08-16 2022-10-26 ガンマデルタ セラピューティクス リミテッド 抗tcrデルタ可変1抗体の治療的使用
GB2586487B (en) 2019-08-21 2024-03-06 Bae Systems Plc Materials Classifier
MX2023009544A (es) 2021-02-17 2023-11-28 Gammadelta Therapeutics Ltd Anticuerpos anti-variable delta 1 de tcr multiespecíficos.
KR20230160253A (ko) 2021-02-17 2023-11-23 감마델타 테라퓨틱스 엘티디 항-tcr 델타 가변 1 항체

Similar Documents

Publication Publication Date Title
CN104822704B (zh) 针对分化簇3(cd3)的人源化的抗体
RU2375375C2 (ru) Гуманизированное анти-cd4 антитело с иммунодепрессивными свойствами
RU2487723C2 (ru) Химерные и гуманизированные антитела к cd44, которые опосредствуют цитотоксичность в отношении раковых клеток
ES2632390T3 (es) Anticuerpos anti-CD20 y métodos de uso
JP2020141671A (ja) 改変された造血幹/前駆細胞及び非エフェクターt細胞、そしてそれらの用途
JP2023526774A5 (cg-RX-API-DMAC7.html)
JP2021516976A5 (cg-RX-API-DMAC7.html)
JP2022513778A (ja) キメラ抗原受容体及びt細胞受容体並びに使用方法
JP2021516975A5 (cg-RX-API-DMAC7.html)
JP2020507328A5 (cg-RX-API-DMAC7.html)
JP2020524506A5 (cg-RX-API-DMAC7.html)
JP2019513370A (ja) キメラ受容体及びその使用方法
JP2020528744A (ja) がん細胞を標的化するキメラ抗原受容体のための方法および組成物
HRP20120701T1 (hr) Humana monoklonska protutijela protiv fukozil-gm1 i postupci za uporabu antifukozil-gm1
HRP20221538T1 (hr) Anti-transtiretinska antitijela
JP2022525377A (ja) 抗bcmaキメラ抗原受容体
JP2023516925A5 (cg-RX-API-DMAC7.html)
CN115916823A (zh) 人cd45rc特异的嵌合抗原受体及其用途
WO2016089610A1 (en) Bispecific antibody for cancer immunotherapy
JP2022517216A5 (cg-RX-API-DMAC7.html)
ZA202403124B (en) Mica antibody with affinity maturation and use thereof
JP2025515092A5 (cg-RX-API-DMAC7.html)
KR20220164473A (ko) 생체외 감마 델타 t 세포 집단
JP2024528877A5 (cg-RX-API-DMAC7.html)
WO2023019121A8 (en) Proteins that decouple t cell-mediated tumor cytotoxicity from release of pro-inflammatory cytokines